Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05145478 · ClinicalTrials.gov registry record
CRUSH PAD: Real-world Outcomes Following Use of Shockwave Intravascular Lithotripsy (IVL) Technology in Calcified Common Femoral Lesions
A clinical trial of Peripheral Arterial Disease and Critical Limb Ischemia, sponsored by Yale University.
- Recruiting
- Registry status
- 50
- Enrollment target
- 2
- Study locations
NCT05145478 is a study of Peripheral Arterial Disease and Critical Limb Ischemia that is actively recruiting participants, run by Yale University. The registered enrollment target is 50 participants, below the 4,206-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT05145478, a study of Peripheral Arterial Disease and Critical Limb Ischemia, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 2
- Study locations
Study Summary
The primary goal of the study is to obtain effect size data on the use of Shockwave Intravascular Lithotripsy (IVL) technology in calcified common femoral lesions in patients with peripheral artery disease for a series of endpoints, including target lesion revascularization and health status, to enable future planning of comparative effectiveness research.
Conditions Studied
Interventions
- DEVICE Shockwave Intravascular Lithotripsy (IVL)
Study Locations (2)
Connecticut
- Yale New Haven Health - New Haven
Rhode Island
- The Miriam Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2021-12-01 |
| Est. Completion | 2027-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05145478
The ClinicalTrials.gov registry entry for NCT05145478 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,206-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (99% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Peripheral Arterial Disease appearing as the primary indexed condition, and to 1 intervention - of which Shockwave Intravascular Lithotripsy (IVL) is the first listed.
NCT05145478 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Connecticut, Rhode Island.
Frequently Asked Questions
What is clinical trial NCT05145478 about?
NCT05145478 is a clinical study titled "CRUSH PAD: Real-world Outcomes Following Use of Shockwave Intravascular Lithotripsy (IVL) Technology in Calcified Common Femoral Lesions". The primary goal of the study is to obtain effect size data on the use of Shockwave Intravascular Lithotripsy (IVL) technology in calcified common femoral lesions in patients with peripheral artery disease for a series of endpoints, including target lesion revascularization and health status, to ena...
What is the current status of trial NCT05145478?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2021-12-01. Estimated completion is 2027-06-01.
What conditions does trial NCT05145478 study?
This clinical trial studies the following conditions: Peripheral Arterial Disease, Critical Limb Ischemia, Claudication, Femoral Arterial Calcification.
What interventions are being tested in trial NCT05145478?
The interventions under investigation include: Shockwave Intravascular Lithotripsy (IVL) (DEVICE).
Who is sponsoring clinical trial NCT05145478?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05145478 being conducted?
This trial has 2 study locations across Connecticut, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Arterial Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
SELUTION4BTK Trial
RECRUITING · NA
-
MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology
RECRUITING · NA
-
A Real-World Registry of Chronic Wounds and Ulcers
RECRUITING
-
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
RECRUITING · Phase 3
-
Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis
RECRUITING · Phase 4
-
Ultrasound Perfusion Estimation for Assessment of Peripheral Arterial Disease
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.